back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-04 19:32 Tx date 2024-03-01 |
$BLCO
Bausch + Lomb Corporation |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-79,945.38
-4,854 vol $16.47 each |
16,766 | |
| Filed 2024-03-04 19:31 Tx date 2024-03-01 |
$BLCO
Bausch + Lomb Corporation |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$233,412
+14,172 vol $16.47 each |
21,620 | |
| Filed 2024-03-04 19:30 Tx date 2024-03-01 |
$BLCO
Bausch + Lomb Corporation |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-233,412.84
-14,172 vol $16.47 each |
227,014 | |
| Filed 2024-03-01 16:53 Tx date 2024-02-28 |
$BLCO
Bausch + Lomb Corporation |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
56 - Grant of rights
|
+100,671 vol |
286,375 | |
| Filed 2024-03-01 16:52 Tx date 2024-02-28 |
$BLCO
Bausch + Lomb Corporation |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
56 - Grant of rights
|
+100,670 vol |
185,704 | |
| Filed 2024-03-01 16:52 Tx date 2024-02-28 |
$BLCO
Bausch + Lomb Corporation |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+152,439 vol |
783,060 | |
| Filed 2024-03-01 16:51 Tx date 2024-02-28 |
$BLCO
Bausch + Lomb Corporation |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+50,335 vol |
241,186 | |
| Filed 2023-07-27 15:47 Tx date 2023-07-25 |
$BLCO
Bausch + Lomb Corporation |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-83,600.76
-4,218 vol $19.82 each |
7,448 | |
| Filed 2023-07-27 15:46 Tx date 2023-07-25 |
$BLCO
Bausch + Lomb Corporation |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$231,220
+11,666 vol $19.82 each |
11,666 | |
| Filed 2023-07-27 15:46 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-07-27 15:44 Tx date 2023-07-25 |
$BLCO
Bausch + Lomb Corporation |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-231,220.12
-11,666 vol $19.82 each |
190,851 | |
| Filed 2023-07-04 17:03 Tx date 2023-06-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
97 - Other
|
$-31,529
-3,845 vol $8.20 each |
79,422 | |
| Filed 2023-07-04 17:02 Tx date 2023-06-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$92,036
+11,224 vol $8.20 each |
83,267 | |
| Filed 2023-07-04 17:02 Tx date 2023-06-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,224 vol |
38,272 | |
| Filed 2023-03-06 15:18 Tx date 2023-03-01 |
$BLCO
Bausch + Lomb Corporation |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
56 - Grant of rights
|
+85,034 vol |
85,034 | |
| Filed 2023-03-06 15:18 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-06 15:17 Tx date 2023-03-01 |
$BLCO
Bausch + Lomb Corporation |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+42,517 vol |
202,517 | |
| Filed 2023-03-06 15:16 Tx date 2023-03-01 |
$BLCO
Bausch + Lomb Corporation |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+136,116 vol |
630,621 | |
| Filed 2022-07-27 17:47 Tx date 2022-07-25 |
$BLCO
Bausch + Lomb Corporation |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+35,000 vol |
160,000 | |
| Filed 2022-06-03 15:00 Tx date 2022-06-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
97 - Other
|
$-38,835.06
-4,058 vol $9.57 each |
72,043 | |
| Filed 2022-06-03 14:59 Tx date 2022-06-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$107,413
+11,224 vol $9.57 each |
76,101 | |
| Filed 2022-06-03 14:58 Tx date 2022-06-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,224 vol |
49,496 | |
| Filed 2022-05-12 08:17 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
494,505 | ||
| Filed 2022-05-12 08:17 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
125,000 | ||
| Filed 2022-03-08 10:53 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-29,323.62
-1,242 vol $23.61 each |
64,877 | |
| Filed 2022-03-08 10:53 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$81,029
+3,432 vol $23.61 each |
66,119 | |
| Filed 2022-03-08 10:52 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,432 vol |
60,720 | |
| Filed 2022-03-03 17:53 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$61,775
+2,537 vol $24.35 each |
64,419 | |
| Filed 2022-03-03 17:51 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-22,353.30
-918 vol $24.35 each |
62,687 | |
| Filed 2022-03-03 17:50 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-19,820.90
-814 vol $24.35 each |
63,605 | |
| Filed 2022-03-03 17:48 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$-61,775.95
-2,537 vol $24.35 each |
||
| Filed 2022-03-03 17:47 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$54,811
+2,251 vol $24.35 each |
56,310 | |
| Filed 2022-03-03 17:46 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-2,537 vol |
64,152 | |
| Filed 2022-03-03 17:45 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-2,251 vol |
66,689 | |
| Filed 2022-03-03 17:43 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-75,533.70
-3,102 vol $24.35 each |
61,882 | |
| Filed 2022-03-03 17:42 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$211,211
+8,674 vol $24.35 each |
64,984 | |
| Filed 2022-03-03 17:40 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-8,674 vol |
6,412 | |
| Filed 2022-03-03 17:39 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+8,674 vol |
15,086 | |
| Filed 2021-06-16 17:08 Tx date 2021-06-11 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-538,585.50
-17,000 vol $31.68 each |
54,059 | |
| Filed 2021-06-04 17:35 Tx date 2021-06-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+122,427 vol |
252,506 | |
| Filed 2021-06-04 17:33 Tx date 2021-06-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+33,673 vol |
68,940 | |
| Filed 2021-03-11 18:12 Tx date 2021-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-242,692.17
-7,361 vol $32.97 each |
71,059 | |
| Filed 2021-03-11 18:11 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,552 vol |
78,420 | |
| Filed 2021-03-11 18:10 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+17,934 vol |
74,868 | |
| Filed 2021-03-11 18:09 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,552 vol |
35,267 | |
| Filed 2021-03-11 18:07 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-17,934 vol |
6,412 | |
| Filed 2021-03-05 18:50 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+8,238 vol |
24,346 | |
| Filed 2021-03-05 18:49 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+16,374 vol |
130,079 | |
| Filed 2021-03-05 18:48 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+10,298 vol |
38,819 | |
| Filed 2021-03-03 20:23 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-54,639.38
-1,739 vol $31.42 each |
52,146 | |
| Filed 2021-03-03 20:23 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$150,438
+4,788 vol $31.42 each |
56,934 | |
| Filed 2021-03-03 20:21 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,788 vol |
28,521 | |
| Filed 2020-03-12 10:21 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-36,659.04
-1,749 vol $20.96 each |
53,885 | |
| Filed 2020-03-12 10:21 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$74,428
+3,551 vol $20.96 each |
55,634 | |
| Filed 2020-03-12 10:20 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-74,428.96
-3,551 vol $20.96 each |
33,309 | |
| Filed 2020-03-11 17:09 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-21,238.36
-869 vol $24.44 each |
52,083 | |
| Filed 2020-03-11 17:08 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$61,979
+2,536 vol $24.44 each |
52,952 | |
| Filed 2020-03-11 17:07 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-61,979.84
-2,536 vol $24.44 each |
36,860 | |
| Filed 2020-03-11 16:28 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+4,502 vol |
16,108 | |
| Filed 2020-03-11 16:28 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+4,502 vol |
11,606 | |
| Filed 2020-03-11 16:27 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+28,429 vol |
113,705 | |
| Filed 2020-03-11 16:26 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+6,753 vol |
39,396 | |
| Filed 2020-02-28 17:22 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-236,631.78
-8,943 vol $26.46 each |
50,416 | |
| Filed 2020-02-28 17:21 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$236,631
+8,943 vol $26.46 each |
||
| Filed 2020-02-28 17:20 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$582,490
+22,014 vol $26.46 each |
59,359 | |
| Filed 2020-02-28 17:19 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$108,380
+4,096 vol $26.46 each |
37,345 | |
| Filed 2020-02-28 17:18 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-8,534 vol |
7,104 | |
| Filed 2020-01-10 12:26 Tx date 2020-01-07 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-125,535.14
-4,267 vol $29.42 each |
32,643 | |
| Filed 2020-01-10 12:25 Tx date 2020-01-07 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$125,535
+4,267 vol $29.42 each |
34,943 | |
| Filed 2020-01-10 12:23 Tx date 2020-01-07 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-49,837.48
-1,694 vol $29.42 each |
33,249 | |
| Filed 2020-01-10 12:22 Tx date 2020-01-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$125,535
+4,267 vol $29.42 each |
||
| Filed 2020-01-10 12:21 Tx date 2020-01-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-125,535.14
-4,267 vol $29.42 each |
||
| Filed 2019-07-23 19:47 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-36,040
-1,696 vol $21.25 each |
16,781 | |
| Filed 2019-07-23 19:46 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$90,652
+4,266 vol $21.25 each |
18,477 | |
| Filed 2019-07-23 19:45 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,266 vol |
50,782 | |
| Filed 2019-06-07 12:54 Tx date 2019-06-04 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-132,050.10
-6,370 vol $20.73 each |
28,106 | |
| Filed 2019-06-07 12:52 Tx date 2019-06-04 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$371,709
+17,931 vol $20.73 each |
34,476 | |
| Filed 2019-06-07 12:51 Tx date 2019-06-04 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-17,931 vol |
41,176 | |
| Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$83,661
+3,551 vol $23.56 each |
17,762 | |
| Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-28,672.52
-1,217 vol $23.56 each |
16,545 | |
| Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-83,661.56
-3,551 vol $23.56 each |
59,107 | |
| Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+7,610 vol |
62,658 | |
| Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+22,149 vol |
85,276 | |
| Filed 2018-03-14 Tx date 2018-03-07 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+7,104 vol |
15,638 | |
| Filed 2018-03-14 Tx date 2018-03-07 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+10,654 vol |
55,048 | |
| Filed 2018-03-14 Tx date 2018-03-07 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$485,598
+31,697 vol $15.32 each |
63,127 | |
| Filed 2018-01-10 Tx date 2018-01-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,266 vol |
44,394 | |
| Filed 2018-01-10 Tx date 2018-01-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$101,744
+4,266 vol $23.85 each |
16,037 | |
| Filed 2018-01-10 Tx date 2018-01-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-43,550.10
-1,826 vol $23.85 each |
14,211 | |
| Filed 2017-06-12 Tx date 2016-06-15 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-12 Tx date 2017-06-07 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-17,930 vol |
48,660 | |
| Filed 2017-06-12 Tx date 2017-06-07 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-77,049.09
-6,159 vol $12.51 each |
11,771 | |
| Filed 2017-06-12 Tx date 2017-06-07 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$224,304
+17,930 vol $12.51 each |
17,930 | |
| Filed 2017-03-06 Tx date 2016-06-15 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-06 Tx date 2017-01-06 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+8,534 vol |
8,534 | |
| Filed 2017-03-06 Tx date 2016-06-15 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
53,791 | ||
| Filed 2017-03-06 Tx date 2017-01-06 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+12,799 vol |
66,590 | |
| Filed 2017-03-06 Tx date 2016-06-15 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-06 Tx date 2017-03-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$451,963
+31,430 vol $14.38 each |
31,430 |